Natural Capsules Ltd.

₹149.72

2.8 (1.9%)

NATCAPSUQ Share Price

Pharmaceuticals & Biotechnology

As on August 14, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 156 Cr

P/E Ratio-6.3

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	158.25	Bearish
10-DMA	155.92	Bearish
20-DMA	150.4	Bearish
50-DMA	151.02	Bearish
100-DMA	153.45	Bearish
200-DMA	165.21	Bearish

Historical Performance

1 Year

-25.5%

3 Years

N/A

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	1,872	1,692	1,554	1,724	1,351
Total Expenditure	1,898	1,516	1,370	1,381	1,108
Other Income	34	8	36	16	22
Operating Profit	8	184	220	359	265
Interest	116	65	53	37	21
Depreciation	171	91	87	72	50
Profit Before Tax	-279	28	81	250	194
Consolidated Net Profit	-247	6	56	184	137
Adjusted EPS	-24	1	6	20	20

Compounded Sales Growth

10 Years:27.9

5 Years:18.7

3 Years:1.7

TTM:2

Compounded Profit Growth

10 Years:50.4

5 Years:4.5

3 Years:-14.3

TTM:69.1

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:N/A

TTM:-25.6

Return on Equity

10 Years:N/A

5 Years:19.6

3 Years:6

last year:-23.7

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	104	103	93	93	70
Total Reserves	2,100	2,222	1,944	1,140	760
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	541	622	712	736	365
Other Current Liabilities	310	236	146	153	110
Short Term Borrowings	450	369	300	220	163
Total Liabilities	4,215	4,194	3,765	2,888	1,643
Capital Work in Progress	37	---	1,438	877	201
Long Term Loans & Advances	26	26	25	22	16
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	335	353	360	328	357
Total Current Assets	1,368	1,296	1,238	1,015	756
Total Assets	4,215	4,194	3,765	2,888	1,643
Adjusted Book Value	212	225	218	133	118

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a low PE of -6.3, which may indicate undervaluation or subdued growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of -40.0%, indicating poor shareholder returns.
The stock carries a low beta of 0.5, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹8 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹1872 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 738555.6

No. of Shares: 4933 (Approx)

Performance:-26.1%

-261444.4

NIFTY Performance: -1.1%

1 day Top Gainers